by Madaline Spencer | Jan 13, 2026
The U.S Food and Drug Administration (FDA) has approved Zycubo (copper histidinate) for the treatment of pediatric patients with Menkes disease. Menkes disease is a rare X-linked pediatric disease caused by gene mutations of copper transporter ATP7A. It affects...
by Madaline Spencer | Jan 13, 2026
Floyd Stewart, patient with stage 4 nasopharyngeal carcinoma, and Monique Stewart, advocate and Floyd’s wife, discuss their family’s experience with the disease and their advocacy work. Nasopharyngeal carcinoma is a rare head and neck cancer arising from...
by Madaline Spencer | Jan 12, 2026
A recent post hoc analysis of long-term efficacy of migalastat in females with Fabry disease was published in the Journal of Medical Genetics. Fabry disease is a rare lysosomal storage disease characterized by a deficiency of the enzyme alpha-galactosidase...
by Madaline Spencer | Jan 9, 2026
The U.S. Food and Drug Administration (FDA) has approved Cablivi (caplacizumab) for the treatment of pediatric patients ages 12 years and older with acquired thrombotic thrombocytopenic purpura (aTTP) in combination with plasma exchange and immunosuppressive therapy. ...
by Madaline Spencer | Jan 9, 2026
Vicki Salemi, Career Expert, discusses current trends in the healthcare job market and expectations for 2026. Recent data from the 2025 Monster Healthcare Market Report shows how the healthcare industry is changing. Through an analysis of healthcare job...
